Frank Boehm of NanoApps Medical and Chakravarthy Lab team

The primary goals of the Chakravarthy Lab are to investigate the pathophysiology and mechanisms of chronic pain in the context of complex regional pain syndrome (CRPS), diabetic neuropathy, persistent postsurgical pain and neuropathic pain.  Further, our lab focuses on how volatile anesthetics and various pain modulators affect host immunity to viral and bacterial infections.

Frank Boehm has been involved with nanotechnology and especially nanomedicine since 1996.

He initiated and serves as CEO of NanoApps Medical Incorporated. The aim of this company is to investigate and develop advanced, innovative, and cost effective nanomedical diagnostic and therapeutic devices and systems for the benefit of individuals in both the developing and developed worlds.

Frank is the author of Nanomedical Device and Systems Design: Challenges, Possibilities, Visions, which was published by CRC Press, and is currently generating two new books. He will serve as Industry Liaison for the Chakravarthay Lab, and work to facilitate and expedite the translation of advanced nanomedical technologies to commercialization on a global scale.

Visit the Chakravarthy Lab site.

Recent News

2018-07-02T11:45:37+00:00

Leave A Comment